Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NBTY Appoints GE Vet To Succeed CEO Rudolph

This article was originally published in The Pink Sheet Daily

Executive Summary

The Carlyle Group, which closed its $4 billion leveraged buyout of NBTY October 1, brought nutritionals neophyte Nagel in to "support and enhance the management team," said NBTY President and Chief Financial Officer Kamil.

You may also be interested in...



NBTY Advertising Drives 44% Income Growth Ahead of Carlyle Acquisition

NBTY says television advertising behind its brands spurred 44 percent growth in net income to $66 million in its latest quarter

Carlyle Group's $3.8B Bid For NBTY Could Face Competition

The Carlyle Group's planned acquisition of NBTY for $3.8 billion may not be the only private equity offer to surface for the dietary supplement giant

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.

Topics

UsernamePublicRestriction

Register

ID1122310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel